Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Inventors

A partnership with MetaCyte is simply that - a full partnership.

For inventors, starting a company is often a random process of seeking advice and figuring out whom they can trust with their ideas, goals, and research findings. As a trusted university and medical center partner, MetaCyte brings specific expertise to the process of health science business creation.

The MetaCyte team provides management, industry expertise, strategy and access to funding. The inventor provides the discovery, the dream and the "spark."

The MetaCyte team recognizes that the next major health science breakthrough can come from any number of health science professionals, including investigators, physicians or engineers. MetaCyte seeks opportunities to help inventors who are ready to commercialize an idea but aren't necessarily ready to leave a full-time academic position or a busy practice.

MetaCyte works with potential company co-founders to evaluate the business potential of their ideas and technologies. If the potential is there, the MetaCyte team uses their extensive business, technical and scientific expertise as well as venture capital contacts to help get the company defined, started and funded.

Click here to learn more about the MetaCyte strategy and business development model.

  • Justin M. Balko, Pharm.D., Ph.D., TrackFive Diagnostics, Inc.
  • E. Penni Black, Ph.D., TrackFive Diagnostics, Inc.
  • Albert R. Cunningham, Ph.D., Gnarus Systems, Inc.
  • Robert Falk, M.D., 3DR Laboratories
  • Ted Kalbfleisch, Ph.D., Intrepid Bioinformatics
  • Claudio Maldonado, Ph.D., EndoProtech
  • Gustavo A. Perez-Abadia, M.D., EndoProtech
  • Norman D. Radtke, M.D., Eyevation, LLC
  • Fred J. Roisen, Ph.D., RhinoCyte
  • Haval Shirwan, Ph.D., ApoImmune
  • Audra Stinchcomb, Ph.D., AllTranz
  • Roland Valdes, Jr., Ph.D., PGxl Laboratories



    "We feel strongly at PGxl Laboratories that our origins at the University of Louisville, relationship with MetaCyte Business Lab, and location in a rich culture of scientific discovery are crucial components to our success."

    Roland Valdes, Ph.D.
    Senior Vice Chair
    Dept. of Pathology & Laboratory Medicine
    University of Louisville
    CEO
    PGxl Laboratories


    "MetaCyte fosters development at a much faster rate, and creates companies, like RhinoCyte, that may not have emerged at all."

    Fred J. Roisen, Ph.D.
    Chair
    Anatomical Science and Neurobiology
    University of Louisville
    President
    RhinoCyte, Inc.


    "My experience with MetaCyte has been great. I have found the team to be very dedicated and knowledgeable. They understand what my goals are and have provided all business support I have needed, resulting in the early stages in receiving our first funding."

    Claudio Maldonado, Ph.D.
    Associate Professor of Surgery
    University of Louisville
    President and CEO
    EndoProtech, Inc.






  • September 10, 2012
    PGXLs Software Makes Drugs More Effective (External Link)

    August 23, 2012
    3DR Laboratories Raises $7.2M from Advantage Capital Partners (External Link)

    July 18, 2011
    Louisville Will Host the 9th Annual MidAmerica Healthcare Venture Forum, November 8-9, 2011 (External Link)

    October 15, 2010
    Intrepid Featured on BioForm (PDF)

    July 16, 2010
    Intrepid Bioinformatics Receives Investment, Meets Milestones

    May 6, 2010
    MetaCyte Business Lab Receives Mention in Nature (PDF)

    March 31, 2010
    MetaCyte Recognized for Innovation

    March 15, 2010
    Teresa Leezer Honored a Second Time for Excellence in Business Management

    February 23, 2010
    Gailar Addresses Leaders as Part of Innovation Panel

    January 2010
    Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

    November 2009
    MetaCyte Advisor Bill Strench Featured in Business First (External Link)

    November 2009
    EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

    July 1, 2009
    AllTranz Named Top Innovator by National Venture Group

    May 8, 2009
    ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

    September 12, 2008
    MetaCyte Team Shows Off New Offices

    June 18, 2008
    Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

    Summer 2006
    A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)